Find a Physician


              

Dong Shin, M.D.
The Emory Clinic
Professor of Hematology and Oncology
Director, Clinical & Translational Cancer Prevention Program


Specialties
Internal Medicine (Board certified since 1985)
Medical Oncology (Board certified since 1989)

Area of Clinical Interest
head & neck cancer
lung cancer
mesothelioma
thymoma


Hospital Affiliation(s)
Emory University Hospital
Emory University Hospital Midtown
Grady Memorial Hospital

Additional spoken language(s)
 Korean

Addresses Locations

Winship Cancer Institute, The Emory Clinic 'C'
1365 Clifton Road, NE Atlanta , GA 30322 Map to the office
(404) 778-1900


Year started practicing at Emory
2003

Education
Medical School
Yonsei University, College of Medicine, Seoul, South Korea 1975

Internship
Yonsei University Hospital, Seoul, South Korea 1979

Residency
Cook County Hospital, Chicago, IL 1985

Fellowship
The University of Texas M.D. Anderson Cancer Center, Houston, TX 1986

Organizational Leadership Memberships
American Association of Cancer Research

American College of Physicians

American Head and Neck Society

American Society of Clinical Oncology

Major or Recent Publications
Combined interferon-á, 13-cis-retinoic acid and á-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel Bioadjuvant Phase II trial. Journal of Clinical Oncology,19:3010-1017, 2001.

P53 protein accumulation and genomic instability in head and neck tumorigenesis.. Cancer Epidermiol Biomarkers and Prevention,10:603-609, 2001.

Phase II Study of Induction Chemotherapy with Paclitaxel, Ifosfamid, and Carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer,95:340-353, 2002.

Phase II and biologic study of interferon-á, 13-cis-retinoic acid, and cisplatin in advanced squamous skin cancer.. Journal of Clinical Oncology,20:364-370, 2002.

Targeting epidermal growth factor receptor: A novel therapeutics in the management of cancer. Exp Reve Anticancer Therapy,3:367-380, 2003.